Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 209 participants.

Also called NCT03720639

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 209 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as a collaborator
Registry
  • NCT NCT03720639
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03720639. Randomized; no masking; primary purpose diagnostic. Start 2018-05-18 (actual); primary completion 2020-03-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study
Condition
Cardiac Arrythmias
Condition
Syncope
Condition
Tachycardia
Condition
Stroke
Intervention (Device)
Abbott, Inc Confirm Rx™ versus Medtronic, Inc Reveal LINQTM
Lead sponsor
Sparrow Clinical Research Institute (class: other)
Collaborator
Abbott (class: industry)

Record details

Record id
cardio:ct-nct03720639
Content hash
09b606e1e22baddadc197144d8a2b6a79cafdd995f12857816e2175366f69917